Takeda Pharmaceutical (Germany) Investor Sentiment

TKD Stock  EUR 25.57  0.18  0.70%   
Roughly 62% of Takeda Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Takeda Pharmaceutical suggests that many traders are alarmed regarding Takeda Pharmaceutical's prospects. The current market sentiment, together with Takeda Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Takeda Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
Takeda Pharmaceutical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Takeda daily returns and investor perception about the current price of Takeda Pharmaceutical as well as its diversification or hedging effects on your existing portfolios.
  
over a week ago at news.google.com         
Takeda Pharmaceutical Updates FY 2024 Earnings Guidance - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
Takeda Pharmaceutical Announces Earnings Results - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
Drugmaker Takedas CEO Weber to step down, raises profit forecast - Reuters
Google News at Macroaxis
over two weeks ago at news.google.com         
Takedas Triple Win Stellar Earnings, Cash Flow Boost, and Massive Buyback Plan Revealed - StockTitan
Google News at Macroaxis
over two months ago at news.google.com         
107,808 Shares in Takeda Pharmaceutical Company Limited Purchased by Verition Fund Management LLC - ...
Google News at Macroaxis
over three months ago at news.google.com         
Tempus Announces Expansion of Collaboration with Takeda to Leverage Multimodal Real-World Datasets a...
Google News at Macroaxis
over three months ago at news.google.com         
Mercer Global Advisors Inc. ADV Lowers Stock Holdings in Takeda Pharmaceutical Company Limited - Mar...
Google News at Macroaxis
over three months ago at news.google.com         
Takeda Pharmaceutical Company Limited Hedge Funds Are Bullish On This Japanese Stock Now - Yahoo Fin...
Google News at Macroaxis
over three months ago at news.google.com         
US allows increased production of Takedas ADHD drug and its generics to address shortage - Reuters
Google News at Macroaxis
over three months ago at news.google.com         
Takeda Pharmaceutical Company Limited Stock Position Raised by Van ECK Associates Corp - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Takeda Pharmaceutical Sees Unusually-High Trading Volume - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Takeda Pharmaceutical Company Limited Shares Acquired by O Shaughnessy Asset Management LLC - Defens...
Google News at Macroaxis
over six months ago at news.google.com         
Takeda Pharmaceutical Is Increasing Its Dividend To 98.00 - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Takeda Pharmaceuticals Upcoming Dividend Will Be Larger Than Last Years - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Takeda Concludes Share Issuance for Employee Incentive Plan - TipRanks.com - TipRanks
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Takeda Pharmaceutical that are available to investors today. That information is available publicly through Takeda media outlets and privately through word of mouth or via Takeda internal channels. However, regardless of the origin, that massive amount of Takeda data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Takeda Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Takeda Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Takeda Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Takeda Pharmaceutical alpha.

Takeda Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Takeda Stock analysis

When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
CEOs Directory
Screen CEOs from public companies around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals